Literature DB >> 8558233

Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone.

R B Gibbs1.   

Abstract

Quantitative in situ hybridization techniques were used to compare relative cellular levels of choline acetyltransferase (ChAT) mRNA in different regions of the female rat basal forebrain at different stages of the estrous cycle and at different time points after the administration of physiological levels of estrogen and progesterone. Significant fluctuations in relative levels of ChAT mRNA were detected during the course of the estrous cycle. In the medial septum (MS) and striatum, the highest levels of ChAT mRNA were detected on diestrus 1. Fluctuations in the nucleus basalis magnocellularis (NBM) were highly variable, with the highest levels detected on diestrus 2. In ovariectomized animals, significant increases in ChAT mRNA were detected in the MS, NBM, and striatum within 1-3 d after a single administration of estradiol. In addition, the effects of estradiol on ChAT mRNA expression in the NBM and striatum were significantly enhanced by the subsequent administration of progesterone. The magnitude and timing of the effects of steroid replacement were consistent with the magnitude and time course of the fluctuations detected during the course of the estrous cycle. These data demonstrate that estrogen and progesterone can increase basal forebrain levels of ChAT mRNA significantly in specific regions of the rat basal forebrain, that the magnitude and time course of the effects vary between different subpopulations of cholinergic neurons, and that the effects are associated with changes in the functioning of specific basal forebrain cholinergic neurons across the estrous cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8558233      PMCID: PMC6578794     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites.

Authors:  Vladimir Znamensky; Keith T Akama; Bruce S McEwen; Teresa A Milner
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

2.  Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women.

Authors:  Julie A Dumas; Amanda M Kutz; Magdalena R Naylor; Julia V Johnson; Paul A Newhouse
Journal:  Neuroimage       Date:  2012-01-12       Impact factor: 6.556

3.  Estrogen-induced increase in the magnitude of long-term potentiation occurs only when the ratio of NMDA transmission to AMPA transmission is increased.

Authors:  Caroline C Smith; Lori L McMahon
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 4.  Estrogens and age-related memory decline in rodents: what have we learned and where do we go from here?

Authors:  Karyn M Frick
Journal:  Horm Behav       Date:  2008-09-16       Impact factor: 3.587

Review 5.  Estrogen-cholinergic interactions: Implications for cognitive aging.

Authors:  Paul Newhouse; Julie Dumas
Journal:  Horm Behav       Date:  2015-07-14       Impact factor: 3.587

6.  An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

Authors:  J I Acosta; R Hiroi; B W Camp; J S Talboom; H A Bimonte-Nelson
Journal:  Brain Res       Date:  2013-01-16       Impact factor: 3.252

7.  Chronic treatment with a GPR30 antagonist impairs acquisition of a spatial learning task in young female rats.

Authors:  R Hammond; D Nelson; E Kline; R B Gibbs
Journal:  Horm Behav       Date:  2012-07-22       Impact factor: 3.587

Review 8.  Gonadal steroids and neuronal function.

Authors:  R Alonso; I López-Coviella
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 9.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

Review 10.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.